Evidence map›Paper›PMID 39711139›Full record

ArticleFuture microbiology2025

Activity of extracts and isolated compounds

Mariane Roberta Ritter, Daniella Renata Faria, Franciele Abigail Vilugron Rodrigues, Danielle Lazarin-Bidóia, Daniela Cristina de Medeiros Araújo, Flavio Augusto Vicente Seixas, Érika Seki Kioshima, João Carlos Palazzo de Mello

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mariane Roberta RitterDepartment of Pharmacy, Pharmaceutical Biology Laboratory, Universidade Estadual de Maringá, Maringá, Brazil.
Daniella Renata FariaLaboratory of Medical Mycology, Department of Health Sciences, Universidade Estadual de Maringá, Maringá, Brazil.
Franciele Abigail Vilugron RodriguesLaboratory of Medical Mycology, Department of Health Sciences, Universidade Estadual de Maringá, Maringá, Brazil.
Danielle Lazarin-BidóiaLaboratory of Technological Innovation in the Development of Drugs and Cosmetics, Department of Health Sciences, Universidade Estadual de Maringá, Maringá, Brazil.
Daniela Cristina de Medeiros AraújoCourse of Pharmacy, Centro Universitário Ingá, Maringá, Brazil.
Flavio Augusto Vicente SeixasDepartment of Technology, Universidade Estadual de Maringá, Umuarama, Brazil.
Érika Seki KioshimaLaboratory of Medical Mycology, Department of Health Sciences, Universidade Estadual de Maringá, Maringá, Brazil.
João Carlos Palazzo de MelloDepartment of Pharmacy, Pharmaceutical Biology Laboratory, Universidade Estadual de Maringá, Maringá, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the

methodsExtracts and fractions of

resultsThe EAF and isolated compounds (cinchonains and procyanidin B2) exhibited significant activity against

conclusionsThe findings suggest that compounds isolated from

Indexed as

Antifungal AgentsCandidaCandida glabrataMeliaceaePlant ExtractsAmphotericin BBiflavonoidsCatechinDrug SynergismHumansMicrobial Sensitivity TestsMolecular Docking SimulationProanthocyanidinsAmphotericin BAntifungal AgentsBiflavonoidsCatechinPlant ExtractsProanthocyanidinsprocyanidin B2Candidacheckerboardelectron microscopymolecular dockingTrichilia catigua

Identifiers

PMID39711139
PMCPMC11812398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.